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Background: Neurofeedback (NF) in children with attention-deficit/hyperactivity
disorder (ADHD) has been investigated in a series of studies over the last years.
Previous studies did not unanimously support NF as a treatment in ADHD. Most studies
did not control for unspecific treatment effects and did not demonstrate that self-
regulation took place. The present study examined the efficacy of NF in comparison
to electromyographic (EMG) feedback to control for unspecific effects of the treatment,
and assessed self-regulation of slow cortical potentials (SCPs).
Methods: A total of 150 children aged 7–9 years diagnosed with ADHD (82% male;
43% medicated) were randomized to 25 sessions of feedback of SCPs (NF) or feedback
of coordination of the supraspinatus muscles (EMG). The primary endpoint was the
change in parents’ ratings of ADHD core symptoms 4 weeks after the end of treatment
compared to pre-tests.
Results: Children in both groups showed reduced ADHD-core symptoms (NF 0.3,
95% CI −0.42 to −0.18; EMG 0.13, 95% CI −0.26 to −0.01). NF showed a
significant superiority over EMG (treatment difference 0.17, 95% CI 0.02–0.3, p = 0.02).
This yielded an effect size (ES) of d = 0.57 without and 0.40 with baseline
observation carried forward (BOCF). The sensitivity analysis confirmed the primary result.
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Successful self-regulation of brain activity was observed only in NF. As a secondary
result teachers reported no superior improvement from NF compared to EMG, but
within-group analysis revealed effects of NF on the global ADHD score, inattention,
and impulsivity. In contrast, EMG feedback did not result in changes despite more
pronounced self-regulation learning.
Conclusions: Based on the primary parent-rated outcome NF proved to be superior to
a semi-active EMG feedback treatment. The study supports the feasibility and efficacy
of NF in a large sample of children with ADHD, based on both specific and unspecific
effects.
Trial Register: Current controlled trials ISRCTN76187185, registered 5 February 2009.
Keywords: ADHD, neurofeedback, slow cortical potentials, randomized controlled study, EMG feedback,
specificity
INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is a common
neurobehavioral disorder in childhood. According to DSM-IV-
TR (in effect during this trial), core symptoms include impaired
attention, hyperactivity, and impulsivity (American Psychiatric
Association, 2000). Stimulant medication represents the most
commonly used intervention for children with ADHD, but
its use is limited since in some children pharmacotherapy
may fail, adverse side effects are common, long-term effects
are not yet established and some parents and clinicians
have reservations about medication use (Sonuga-Barke et al.,
2013).
Among additional or alternative treatments for ADHD
neurofeedback (NF) has gained promising empirical support
in recent years. Based on the observation of deviant slow
event-related potentials in children with ADHD, feedback
of slow cortical potentials (SCPs-NF) aims at improving
the neurophysiological profile of children with ADHD by
self-regulation of cortical excitation thresholds (Banaschewski
and Brandeis, 2007; Albrecht et al., 2013; Doehnert et al., 2013).
SCPs are slow event-related changes in the EEG, reflecting
cognitive and motor preparation (Birbaumer et al., 1990). Studies
have demonstrated promising effects on behavior, cognitive,
and electrophysiological measures after SCP-NF (Heinrich et al.,
2004; Strehl et al., 2006; Drechsler et al., 2007; Gevensleben et al.,
2009; Christiansen et al., 2014; Maurizio et al., 2014).
A recent meta-analysis failed to support NF as an effective
treatment for ADHD but this result may reflect methodological
weaknesses of the available studies rather than the weakness
of NF as such (Cortese et al., 2016). When the analysis was
restricted to trials meeting Arns et al.’s (2014) criteria for a
standard (established) NF protocol (as related to the target EEG
measures, to number and placement of electrodes, trials designed
Abbreviations: AE, adverse events; CBCL, Child Behavior Checklist; CGI-I,
Clinical Global Impression-Improvement Scale; CPM, Coloured Progressive
Matrices; EMG, electromyographic feedback; EOG, electrooculogram; IZKS,
Interdisciplinary Center for Clinical Trials; mITT, modified intention-to-treat
(population); NF, neurofeedback; PP, per-protocol (population); SAE, serious
adverse events; SCP, slow cortical potential; SDQ, Strengths and Difficulties
Questionnaire.
in line with principles of learning theory, involving techniques
to promote generalization to everyday life and assessing whether
learning took place), significant effects emerged also applying
probably blinded ratings.
The main drawbacks of previous SCP studies are
methodological shortcomings like lack of appropriate control
conditions, intent-to-treat analyses, unblinded outcome
measures, limited testing for successful self-regulation at the
brain level, and failure to control unspecific effects and variables
(e.g., amount of reinforcement, time, attention of and interaction
with the therapist; sex, age, baseline severity, expectations, and
satisfaction with treatment). To disentangle NF-specific and
unspecific effects influencing the outcome of any treatment the
choice of a control condition is of major importance (Oken,
2008). Active control conditions do not control for unspecific
effects as the independent variables causing them differ as
regards, e.g., to setting, expectation, interaction, time, and effort.
For example, medication cannot control for the unspecific effects
of time and attention spent concentrating on the challenging
self-regulation task, and for the experience of learning with
contingent feedback. Double-blind studies which employ a sham
condition may provide strong unbiased evidence regarding
efficacy and specificity, and thus have clear merits in NF research
(The Collaborative Neurofeedback Group, 2013) which may
involve considerable non-specific effects (Drechsler et al., 2007;
Thibault and Raz, 2016). While double-blind controlled placebo
studies in general may provide strong evidence regarding efficacy
and specificity, the establishment of sham conditions for NF
treatments has shown to be at least doubtful if not missing the
main aim. Patients and trainer can detect the sham condition
and may refuse further participation (Birbaumer et al., 1991).
Another outcome was observed by van Dongen-Boomsma
et al. (2013). Here the majority of patients in the NF condition
assumed that they were assigned to the sham condition. As
any acquisition of a new skill, learning to self-regulate brain
activity takes time. The lack of success in the first sessions
may lead to the impression of being allocated to an ineffective
control condition. As a consequence, this may impair motivation
and compliance. However, apart from potential ethical and
expectancy motivation problems of sham designs, an ideal
control condition for NF should also require learning to fully
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match moderator variables such as motivation, frustration,
compliance, and the often stepwise experience of self-efficacy
(Gevensleben et al., 2014). Recent neuroimaging research
demonstrates specific increases of activity in brain regions
supporting inhibitory control following learning of different
types of self-regulation in ADHD (Baumeister et al., 2016).
Therefore, sham conditions that do not allow learning genuine
contingencies also have limitations (Sherlin et al., 2011; Arns
et al., 2014). To induce learning of self-regulation but limited
to peripheral rather than central nervous targets, we chose a
semi-active control condition according to the classification
put forward by Arns et al. (2014) in comparing NF with
electromyographic (EMG) feedback. Despite not being closely
related to the known pathology of ADHD, EMG feedback has
been used in several ADHD treatment studies and as a control
condition for NF. Some improvements but smaller than those
from NF were reported (Arnold, 2001; Bakhshayesh et al.,
2011; Maurizio et al., 2014). Thus, even participants in the
control condition have the chance to reduce symptoms and
learn self-regulation, but not based on a treatment specific to
the pathology of the disease. Delivering identical treatment
elements in both conditions apart from the specific (NF or EMG)
component should allow differentiating specific from unspecific
effects of NF.
The aim of this investigation was to assess the effectiveness,
specificity and feasibility of SCP-NF in comparison to EMG
feedback in a prospective, randomized and controlled study,
while neurophysiological data and more detailed learning
analyses and correlations with clinical outcomes will be published
elsewhere (see Materials and Methods).
MATERIALS AND METHODS
Study Design
Study design, methods, and data analysis plan are described
in detail in the study protocol published by Holtmann
et al. (2014). Patients were recruited and treated in five
German university-based outpatient departments for child
psychiatry/psychotherapy. All local ethics committees approved
the study. Patients’ assent was obtained by using age appropriate
information and their parents or guardians gave written informed
consent. Figure 1 depicts the design and study flow.
Study Groups
Inclusion criteria comprised age from 7 to 9 years, and a
diagnosis of ADHD combined type according to DSM-IV TR
verified in a semi-structured interview under the supervision
of clinical psychiatrists/licensed psychologists (Delmo et al.,
1998). In the case of positive screenings for comorbid symptoms
assessed by the Child Behavior Checklist (CBCL; Arbeitsgruppe
Deutsche Child Behavior Checklist, 1998), corresponding
parents’ rating scales were applied (Döpfner and Lehmkuhl,
2000; Döpfner et al., 2006). Exclusion criteria consisted of
a diagnosis of bipolar disorder, psychosis, serious obsessive–
compulsive disorder, chronic severe tics or Tourette syndrome,
major neurological or physical illness, acute suicidal tendencies,
pharmacotherapy for severe anxiety, mood disorders and
psychosis, IQ below 80, lack of German-language proficiency
in the child or primary caregiver, no telephone, pregnancy
and lactation, and current participation in other clinical
trials.
As the interventions were considered an add-on to treatment
as usual pharmacotherapy for ADHD, Oppositional Defiant
Disorder and Conduct Disorder were allowed.
Patients were randomly assigned in a 1:1 ratio with varying
block size to either the experimental or the control group.
This assignment was realized by a computer-generated,
web-based tool provided by the Interdisciplinary Center for
Clinical Trials (IZKS) Mainz. Randomization was stratified
per trial site and sex. Medical consultants rating clinical
impairments were blinded. Participants were not blinded,
because they were instructed according to their group
assignment. Parents were not informed about treatment
allocation but as the children were given instructions according
to their treatment group, parents could infer their child’s group
assignment.
Procedures
After screening, there was a washout period of 2 weeks for
children with psychostimulants and 4 weeks for participants with
atomoxetine. Pre-tests and post-tests 2 were conducted without
medication. After the pre-test, children resumed their medication
until completion of post-tests 1. The main outcome therefore was
assessed by changes in post-tests 2 compared to pre-tests (see
Figure 1).
Participants received 25 training sessions within 3 months
with two to three sessions per week. After session 12, there was
a break of 4–6 weeks. Such a break has become standard in
clinical NF studies to disburden the patients from the demanding
training schedule with two to three sessions per week and to give
him/her the opportunity to practice self-regulation in everyday
life (transfer).
Experimental Group: NF of SCP
SCPs are very slow shifts in the EEG near to 0 Hz, typically
generated in an event-related design for several seconds.
A negative shift reduces the excitability of the underlying
cortical area while a positive shift is understood as inhibition
of excitation and/or consummation of energy. As event-
related potentials they prepare adequate cognitive as well as
motor responses. In the feedback paradigm, participants were
prompted to either produce negative (reducing the excitability
threshold of the underlying cortex) or positive shifts (inhibition
of excitation) in a randomized order. After session 12, the
ratio of negativity to positivity trials was increased from
50 to 80%. The convention in SCP training so far has
been to train and reinforce both polarities to improve self-
regulation, but particularly toward the end focus on that polarity
which is thought to be related to the disease (e.g., Strehl
et al., 2006). As the neurophysiological profile of patients
with ADHD indicates hypoactivation of cortical excitation
thresholds, the training of negative shifts is thought to be more
important.
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FIGURE 1 | Study flow (modified from Holtmann et al., 2014).
Control Group: Feedback of Electromyographic
Coordination of the Supraspinatus Muscles
As a semi-active control condition EMG feedback of
coordination in the supraspinatus muscles was chosen.
Participants were instructed either to contract or to relax
the left relative to the right supraspinatus muscle. This protocol
was chosen to induce differential EMG control corresponding
to the “polarities” comparable to the NF condition, without
requiring simple relaxation or tension. This allowed us to use the
same device and the same representation of the feedback signal
on the screen. We did not choose a standard EMG feedback
protocol because the control condition should be as unspecific as
possible but include the possibility to learn self-regulation, i.e.,
the unspecific variable of any biofeedback treatment.
Common Components of Behavior Therapy in Both
Groups
All interventions took place in outpatient clinics. Setting, training
devices, electrode montage, feedback and transfer trials, number
of sessions, transfer exercises, and the possibility to earn tokens
were the same in both groups.
The treatment schedule (Figure 2) for each session comprised
four blocks of 40 trials each. Each trial lasted for 10 s (2 s baseline
and 8 s feedback and depicting a “sun” after successful trials).
In all sessions, the third block operated without continuous
feedback; only the sun was shown at the end if the trial had been
successful (Figure 2). These trials were part of several measures
to carry over self-regulation skills to everyday life:
During the break following session 12, patients were asked
to practice self-regulation at home using small memo cards
depicting the screen during a task. In addition, self-regulation
could be trained with the help of a video showing a sequence
of both positivity and negativity trials. After each of the 10
final sessions, the children did part of their homework in the
lab under the trainer’s supervision making use of the memo
cards.
As a reward for their participation and for good cooperation
children could earn tokens. Whenever a certain number was
achieved, tokens were swapped for vouchers or small gifts.
Acquisition of EEG- and EMG-Signals
EEG and EMG were recorded and fed back with a multichannel
amplifier (THERA PRAX R© neuroConn GmbH, Ilmenau,
Germany). The EEG electrode was placed at Cz, referenced
against the mastoid behind the right ear. Four electrodes were
used to record the vertical and horizontal electrooculogram
(EOG) and one electrode behind the left ear was used as ground.
EMG was recorded with one electrode per shoulder placed at the
upper area of the right and left supraspinatus muscle.
Off-line analyses were performed with the Brain Vision
Analyzer (Version 2.0, Brain Products, Gilching, Germany).
For training data, EEG was filtered off-line using a 0.01 Hz
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FIGURE 2 | Treatment schedule.
high cut-off filter (12 dB/octave) plus 50 Hz notch filter,
referenced with one mastoid, followed by ocular correction
(Gratton et al., 1983). Data were segmented for both
tasks (positive and negative SCP shifts). Artifacts were
rejected semi-automatically if trials were over ±150 µV.
Remaining artifact free trials were averaged. The average
was exported using the last 4–8 s of every trial that
lasted 8 s.
Each center was guided by a detailed manual to ensure
equal handling of participants, testing, and treatment. Center
representatives met for an initial 2-day training course and on a
regular basis thereafter. Supervision visits took place to guarantee
compliance with the manual.
Outcomes
Psychometric properties of all pre-specified measures are
reported in Holtmann et al. (2014). For the present first paper
outcomes are reported as changes from pre-test to post-test 2
(after washout of medication, defined a priori as the primary
endpoint to avoid residual medication confounds, and to focus
on stable or sustained SCP-NF effects). Apart from IQ and
cortical self-regulation, a detailed analysis of learning parameters,
electrophysiological, neuropsychological outcomes, and 6-month
follow-up data will be reported elsewhere.
The primary endpoint was the parent-rated ADHD symptom
severity assessed using the mean global score of the German
ADHD rating scale (24). The scale consists of 20 items assessing
the severity of inattention, hyperactivity, and impulsiveness. Each
item, corresponding to one of the DSM-IV diagnostic criteria, is
rated on a 4-point scale (0 = never or rarely; 1 = sometimes;
2= often; 3= very often).
Secondary endpoints were:
– Parents’ ratings of ADHD subdomains (inattention,
hyperactivity, impulsivity; Döpfner et al., 2006).
– Teachers’ ratings of ADHD symptoms (global score and
subdomains; Döpfner et al., 2006).
– The Clinical Global Impression-Improvement (CGI-I)
responder status assessed by a blinded clinician (Guy,
1976).
– Comorbid symptoms [parents’ and teachers’ ratings via the
Strengths and Difficulties Questionnaire (SDQ); Woerner
et al., 2004].
– Full scale IQ [indicated by its percent rank; measured
with parallel versions of the Coloured Progressive Matrices
(CPM) to minimize test–retest effects; Bulheller and
Häcker, 1998.
– Quality of life assessed via the global score of the revised
German Kid-KINDL(R) (Ravens-Sieberer and Bullinger,
1998).
– Parents’ satisfaction with therapy: unpublished
questionnaire developed by the Institute of Medical
Psychology and Behavioral Neurobiology, Tübingen
(2004). Parents submitted these questionnaires directly to
the IZKS to guarantee anonymous handling and thereby
avoiding responses driven by social desirability.
– Adverse events (AE) and serious adverse events (SAE): at
each contact participants were asked to report any AE and
their severity using open questions.
As covariates, we assessed parenting style and parents’
expectations (Arnold et al., 1993) at screening. Self-regulation
of EEG during training sessions was assessed to evaluate the
specificity of NF.
Statistical Analysis
The methodology for processing and analyzing the data was
documented in a Statistical Analysis Plan (SAP) dated and
maintained by the IZKS responsible for data management,
monitoring, and analysis (for details, see Holtmann et al., 2014).
Sample size calculation for the primary endpoint was based on
an estimation of effect sizes derived from the SCP-NF study
by Heinrich et al. (2004) using the same outcome measure.
Expecting a mean ADHD score of 1.2 at post-test 2 in the NF
group and of 1.5 in controls with a common SD of 0.55 a sample
size of 72 per group was required to achieve a power of 90%
(α= 0.05, two-sided t-test).
Data were analyzed primarily in the modified intention-to-
treat (mITT) population, comprising all randomized patients
except those who received no treatment due to violation of
inclusion criteria. Supportive analysis was performed in the
per-protocol (PP) population, comprising all mITT patients
who did not meet any of the following criteria: violation of
inclusion or exclusion criteria, major deviations from the visit
schedule, and lack of compliance during treatment sessions.
Safety parameters were analyzed in the safety population,
comprising all participants with at least one feedback session.
The primary outcome was tested by an analysis of covariance
(ANCOVA) with treatment, trial site, sex, baseline ADHD
score, baseline ADHD medication, parenting style, and parents’
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FIGURE 3 | CONSORT flow diagram.
expectations as covariates. Missing ADHD scores were imputed
according to the baseline observation carried forward (BOCF)
method. This is usually considered a conservative approach
to handle missing data since patients with missing values are
treated as treatment failures. This conservative approach is
supposed to avoid too positive results, when many patients
from the NF treatment group dropout who do not improve
or even get worse. Therefore, the analysis was repeated with a
multiple imputation approach. Additional covariates were used
to create 10 complete datasets. Those datasets were analyzed by
the same ANCOVA model as the primary analysis. Afterward,
the results were combined by Rubin’s rules. Secondary analyses
comprised ANCOVAs (analogously to the primary analysis) for
differences in ADHD global and subdomain scores (teachers’
ratings), t-tests for differences in ADHD global scores (parents’
ratings, teachers’ ratings), SDQ subscales, IQ, quality of life,
and parents’ satisfaction with therapy. For the binary variable
Clinical Global Impression (CGI) McNemar’s tests were used
to test for differences between time points within groups, and
chi-squared tests were used for differences between groups.
Results of all statistical tests except for the primary analysis
must be interpreted in an exploratory manner. To assess the
magnitude of treatment effects, between-treatment effect sizes
were calculated by dividing the treatment-group differences
(including the BOCF method if indicated) by the pooled
standard deviation at pre-test. Within-treatment effect sizes were
calculated by dividing the mean of changes by the standard
deviation at pre-test.
To assess the extent and specificity of SCP self-regulation, the
mean amplitude of SCPs and mean self-regulation performance
(percentage of correct trials) were averaged for training sessions
2 + 3, 10 + 11, 14 + 15, and 23 + 24. These session averages
were selected in line with previous work (Strehl et al., 2006). This
selection provides robust estimates of regulation performance
and learning, while excluding the undesired influences of novelty
or expected completion in the initial and final sessions of each
training half. SCP amplitude (µV) was analyzed using group by
task× sessions (only the four session averages during training to
minimize the number of dropouts) repeated-measures ANOVAs.
Self-regulation performance was analyzed using a group by
sessions (the four session averages during training plus post 2
performance) repeated-measures ANOVA. SCP amplitude and
self-regulation performance were analyzed separately for the
feedback and transfer condition.
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TABLE 1 | Baseline characteristics of participants.
Neurofeedback N = 75 EMG feedback N = 69
Variable Mean SD Mean SD
Age (in years) 8.60 0.92 8.57 0.88
ADHD global score 1.84 ±0.45 1.78 ±0.47
KINDL(R) Quality of Life 67.5 8.9 68.6 9.6
CPM (percentage rank) 63.4 27.0 65.5 27.0
CBCL t-value
Global 63.6 8.4 63.2 7.8
Externalizing problems 66.3 9.4 64.8 9.4
Internalizing problems 62.2 9.5 62.4 9.3
N Percent N Percent
CBCL Comorbidity∗
Oppositional defiant disorder 31 41.33 32 46.36
Conduct disorder 0 0.00 1 1.45
Depression 11 14.66 8 11.59
Dysthymia 5 6.67 3 4.35
Separation anxiety 3 4.00 5 7.25
General anxiety disorder 18 24.00 18 27.69
Social phobia 4 5.33 8 11.59
Specific phobia 4 5.33 6 8.64
Sex
Female 14 18.67 11 15.94
Male 61 81.33 61 84.06
CGI-S
Normal/Borderline ill 3 5.00 3 5.36
Mild/Moderately ill 29 48.33 29 45.78
Marked/Severely ill 28 46.67 24 42.86
Missing 15 13
ADHD medication prior to study 34 45.33 28 40.58
CGI, Clinical Global Impression-Severity; CBCL, Child Behavior Checklist; ∗disorder-specific parent ratings.
An independent data monitoring and safety board supervised
the conduct of the study. The trial was registered under Current
Controlled Trials ISRCTN76187185 (5 February 2009).
RESULTS
Patients
A total of 174 participants were recruited between September
2009 and January 2013 for screening, 150 of whom were allocated
to one of the two treatment groups. In NF 60 and in EMG 51
participants completed treatment and took part in all assessment
points. The CONSORT flow diagram is depicted in Figure 3.
The mITT population comprised 75 participants in NF and 69
in EMG. Baseline characteristics are depicted in Table 1. There
were no differences between groups in any of these variables.
The safety population comprised 96% of the mITT population
for NF and 98.55% for EMG; the PP population consisted
of 59% for NF and 58% for EMG. The main reason for
violation of the protocol was delay of post-tests 2, which
occurred in 41% of NF and in 42% of EMG mITT populations.
NF had 16% dropouts, EMG 17%, with most dropouts
occurring between pre-test and session 12. A comparison
between dropouts and non-dropouts yielded the following
differences: lower level of education of fathers (p = 0.03—chi-
squared test), fewer parents living together (p = 0.027—chi-
squared test), and more severe oppositional defiant disorder
(p = 0.033—t-test) in those who did not complete the
study.
Primary Outcome
NF was significantly superior to EMG in reducing ADHD
core symptoms as rated by parents with a difference of 0.17
(95% CI 0.02–0.30, F(1) = 5.30, p = 0.02). ANCOVA yielded
no impact of sex, trial site, medication status at baseline,
parenting style, and parents’ expectations on the reduction of
ADHD core symptoms as rated by parents (Table 2). The more
pronounced ADHD symptoms were at pre-test the larger was
their reduction.
The sensitivity analysis with the PP population (N = 84)
yielded similar results (Supplementary Table S1). The multiple
imputation approach revealed similar results: the difference
between treatments was 0.22 (95% CI 0.03–0.4), p = 0.02. The
difference of changes in the ADHD global score between groups,
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TABLE 2 | Primary analysis: Differences in ADHD global score (parents’
ratings; post-test 2 minus pre-test between groups; mITT population,
ANCOVA, baseline observation carried forward); df, degree(s) of freedom.
Adjusted mean (95% CI) p F df
EMG feedback −0.1338 (−0.259/−0.008)
Neurofeedback −0.2987 (−0.416/−0.181)
Difference between
treatments
0.1649 (0.023/0.301)
Treatment 0.0230 5.30 1
Baseline ADHD global
score
0.0008 11.84 1
Sex 0.1879 1.75 1
Trial site 0.5951 0.70 4
Baseline ADHD
medication (yes/no)
0.3016 1.08 1
Parenting style (mean) 0.8007 0.06 1
Parents’ expectations
(mean)
0.4154 0.67 1
as compared by a t-test, was significant for the mITT population
(BOCF), at p= 0.01 (NF mean−0.35, SD 0.42; EMG mean−0.17,
SD 0.43), and yielded an ES of d = 0.57 without BOCF and 0.40
with BOCF. Within-group analyses revealed effect sizes of 0.78
for NF and 0.35 for EMG. Global score changes from pre-test to
post-test 2 are depicted in Figure 4.
Secondary Outcomes
Parents’ Ratings of ADHD Subdomains
Data for all scales at pre-test and post-test 2 are reported in the
Table 3 (BOCF). For results without BOCF, see Supplementary
Table S2.
Table 4 shows the adjusted mean difference of change scores
post-test 2 minus pre-test between groups (BOCF). Both groups
improved in the subdomain hyperactivity, although no difference
between groups was observed. Parents’ ratings indicated superior
improvements in the NF group for the subscales impulsivity
(p = 0.02) and inattention (p = 0.02) with medium effect sizes.
Similar to the primary analysis none of the covariates had an
impact on treatment differences.
Teachers’ Ratings of ADHD Core Symptoms
The difference between groups based on teachers’ ratings of
ADHD global scores (mITT population, ANCOVA, BOCF;
Supplementary Table S3) was not significant [treatment
difference 0.04, 95% CI −0.12 to 0.21, F(1) = 0.25, p = 0.62].
ANCOVA yielded a significant within-group difference for NF
(mean change of−0.16; 95% CI−0.3 to−0.02) but not for EMG
(mean change of−0.11; 95% CI−0.26 to 0.04). Data for all scales
at pre-test and post-test 2 are reported in Table 5 (BOCF); for
results without BOCF, see Supplementary Table S4.
Post hoc t-tests for changes from pre-test to post-test 2 in
global score and subscores yielded no differences between groups
(see Table 6). According to within-group analyses, improvements
in global scale, inattention, and impulsivity were observed for NF
only, albeit with small effect sizes.
Clinical Global Impression
Clinicians did not observe significant differences between groups
regarding the responder status. At post-test 2 the percentage of
responders was 27% (NF) and 26% (EMG). The analysis was
limited due to a large proportion of missing values (about 40%
of the mITT population in both groups).
Comorbid Symptoms (SDQ)
No difference between groups was observed regarding changes in
comorbid symptoms between pre-test and post-test 1, as assessed
with parents’ ratings. Children were rated as slightly improved in
both groups.
Full Scale IQ (CPM)
A significant difference between groups was observed regarding
the change in full scale IQ from pre-test to post-test 2 (p = 0.04,
ES = −0.37). While the percentage rank in the EMG group
declined from pre- (mean 65.5, SD 25.7) to post-assessment
(mean 59.9, SD 31.4) it improved in the NF group from pre-
(mean 63.4, SD 28.0) to post-assessment (mean 65.7, SD 28.0).
Quality of Life [KINDL(R)]
There was no change from pre-test to post-test 2. Scores in both
groups ranged from 68 to 72, which is below the standard values
of healthy children (Ravens-Sieberer and Bullinger, 1998).
Parents’ Satisfaction with Treatments
There were no differences in parents’ ratings regarding their
satisfaction with the treatment. Mean values were 4.1 (SD 1.6)
for NF and 4.4 (SD 1.4) for EMG on the 6-point Likert scale.
Adverse Events and Serious Adverse Events
In the safety population (N = 140) 119 AE were reported. At
least one AE was reported in 33% of NF participants and 35% of
EMG participants. A possible causal relation with the treatment
was stated in 4 (6%) of NF participants and 5 (7%) of EMG
participants. These children reported headaches (N = 4, both
groups), skin reactions (n = 3, NF), myalgia (n = 1, EMG),
and nausea (n = 1, EMG). SAE were reported for two children
in each group (deterioration of ADHD: n = 2, EMG; n = 1,
NF; psychological trauma after traffic accident: n = 1, NF). One
of these children (EMG group) was withdrawn from the study
because ADHD symptoms deteriorated.
Self-Regulation of EEG
For the SCP amplitude averaged over all training sessions, a
significant interaction was observed between shift direction
(trial polarity) and group (p ≤ 0.0001, η2 = 0.18). Only
the SCP-NF group differentiated between EEG polarities
(p < 0.0001), achieving negative mean amplitudes in
negativity trials and positive amplitudes in positivity trials.
These correct polarities were only achieved in the feedback
condition, while the transfer condition did not show
significant differences between polarities or groups (see
Figure 5).
Repeated-measures ANOVA for self-regulation performance
during feedback trials revealed a significant main effect of
session (p < 0.001, η2 = 0.067) and a group × session
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FIGURE 4 | Least square means of ADHD global score changes from pre-test to post-test 2 (parents’ and teachers’ ratings; mITT population,
ANCOVA, baseline observation carried forward).
TABLE 3 | Parents’ ADHD ratings (mITT population N = 144, BOCF).
NF EMG Total
Pre-test Post-test 2 Pre-test Post-test 2 Pre-test Post-test 2
Hyperactivity
N 72 73 67 68 139 141
Mean (SD) 1.54 (0.63) 1.22 (0.71) 1.52 (0.67) 1.33 (0.66) 1.53 (0.64) 1.28 (0.68)
Missing 3 2 2 1 5 3
Impulsivity
N 72 73 67 68 139 141
Mean (SD) 1.93 (0.65) 1.59 (0.65) 1.80 (0.78) 1.71 (0.76) 1.87 (0.73) 1.65 (0.71)
Missing 3 2 2 1 5 3
Inattention
N 72 73 67 68 139 141
Mean (SD) 2.03 (0.53) 1.64 (0.59) 1.97 (0.51) 1.80 (0.48) 2.00 (0.52) 1.72 (0.54)
Missing 3 2 2 1 5 3
Global score∗
N 72 73 67 68 139 141
Mean (SD) 1.84 (0.49) 1.49 (0.55) 1.78 (0.47) 1.62 (0.50) 1.81 (0.46) 1.55 (0.53)
Missing 3 2 2 1 5 3
∗Global score could not be assessed if more than two items in subscales were missing.
TABLE 4 | Adjusted mean differences in ADHD subdomain scores (parents’ ratings; post-test 2 minus pre-test between groups; mITT population,
ANCOVA, BOCF).
Neurofeedback N = 75 (23 BOCF) EMG feedback N = 69 (20 BOCF) Difference
Variables Mean 95% CI Mean 95% CI Mean 95% CI p ES
Hyperactivity −0.28 −0.42/−0.13 0.17 −0.33/−0.02 0.11 −0.07/0.28 0.23 0.18
Impulsivity −0.30 −0.45/−0.15 −0.09 −0.25/0.07 0.21 0.03/0.39 0.02 0.34
Inattention −0.31 −0.44/−0.18 −0.13 −0.27/0.01 0.18 0.03/0.36 0.02 0.40
interaction (p < 0.006, η2 = 0.054). The EMG-NF group
achieved higher self-regulation rates compared to the SCP-NF
group (p < 0.0001). Post hoc comparisons showed that the SCP-
NF group improved significantly self-regulation at post 2, and
the EMG group improved performance over sessions, however,
there the last session was not different from the first one. For
the transfer condition, repeated-measures ANOVA showed a
significant main effect of session (p < 0.001, η2 = 0.044) but
no group× session interaction. The EMG group achieved higher
self-regulation rates compared to the SCP-NF group (p< 0.0001).
Post hoc comparisons showed that only the EMG group enhanced
performance over time (see Figure 6).
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TABLE 5 | Teachers’ ADHD ratings (mITT population N = 144, BOCF).
NF EMG Total
Pre-test Post-test 2 Pre-test Post-test 2 Pre-test Post-test 2
Hyperactivity
N 68 70 63 64 131 134
Mean (SD) 1.15 (0.81) 1.05 (0.79) 1.02 (0.85) 1.02 (0.77) 1.09 (0.83) 1.04 (0.78)
Missing 7 5 6 5 13 10
Impulsivity
N 68 70 63 64 131 134
Mean (SD) 1.41 (0.95) 1.24 (0.94) 1.31 (0.95) 1.27 (0.92) 1.36 (0.95) 1.25 (0.93)
Missing 7 5 6 5 13 10
Inattention
N 68 70 63 64 131 134
Mean (SD) 1.69 (0.70) 1.59 (0.70) 1.68 (0.72) 1.60 (0.68) 1.69 (0.71) 1.60 (0.69)
Missing 7 5 6 5 13 10
Global score∗
N 65 69 60 61 125 130
Mean (SD) 1.48 (0.64) 1.34 (0.68) 1.38 (0.71) 1.32 (0.71) 1.43 (0.67) 1.33 (0.66
Missing 10 6 9 8 19 14
∗Global score could not be assessed if more than two items in subscales were missing.
TABLE 6 | Mean differences (SD) in ADHD global and subdomain scores (teachers’ ratings; post-test 2 minus pre-test between and within groups; mITT
population, BOCF).
Within group analysis
Neurofeedback N = 75 (26 BOCF) EMG feedback N = 69 (28 BOCF) Between groups analysis
Variables Mean SD p ES Mean SD p ES P ES
Hyperactivity −0.11 0.70 0.22 0.13 −0.01 0.56 0.86 0.01 0.40 0.11
Impulsivity −0.20 0.70 0.03 0.21 −0.06 0.62 0.45 0.06 0.24 0.15
Inattention −0.13 0.53 0.04 0.19 −0.08 0.43 0.16 0.11 0.51 0.08
Global score∗ −0.15 0.54 0.03 0.23 −0.07 0.41 0.19 0.10 0.36 0.12
∗NF: N = 47; EMG: N = 39 because global score could not be assessed if more than two items in subscales were missing.
FIGURE 5 | Self-regulation of SCP amplitude by group (NF vs. EMG) and task (polarity; positivity vs. negativity).
Self-Regulation Performance and its Relation to
Clinical Changes
To assess the impact of self-regulation performance on the
clinical outcome we grouped participants into learners and non-
learners based on the sign of their regression slope for the
feedback and the transfer condition separately. For the feedback
condition 67.9% were classified as learners in the SCP-NF group,
while 71.1% in the EMG group were classified as learners. For the
transfer condition, 53.7% of the SCP-NF group and 73.7% of the
EMG group were classified as learners.
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FIGURE 6 | Self-regulation performance during feedback and transfer trials: (A) SCP-NF group and (B) EMG-NF group.
No significant correlation between performance and clinical
outcome was obtained for either group on the primary parent-
rated outcome or the corresponding secondary teacher rated total
score.
Post hoc Analyses
Response status was defined based on CGI; however, there were
too many missing data for the analysis. We therefore assessed the
responder rates based on a >25% improvement on the parent
rated ADHD global score from pre-test to post-test 2. As a result,
NF yielded a responder rate of 52% and EMG of 35% (mITT
population). Based on BOCF analysis we observed 38% responder
after NF and 25% after EMG feedback.
To explore possible reasons for the difference between parents’
and teachers’ ratings we computed an independent samples t-test
(Satterthwaite). Teachers rated symptoms as less severe than
parents did (see Table 7).
DISCUSSION
This is the first randomized controlled clinical trial to investigate
the specificity of SCP feedback in children with ADHD, and
the largest study on an outpatient ADHD sample treated with
NF. We compared two treatments (SCP-NF and EMG feedback)
using identical training setups to control for unspecific effects.
For the first time in NF research a BOCF approach was used
to handle missing data. This study confirmed specific positive
effects of SCP-NF on parent-rated ADHD symptom severity,
with a significant greater decrease in symptoms compared to
EMG feedback. Sex, trial site, medication, parenting style, and
parents’ expectation had no impact on the ADHD score change.
Sensitivity analyses with multiple imputation and with the PP
population generated comparable results. These results are in
line with previous findings of trials comparing NF to semi-active
control groups (Arns et al., 2014). Symptom severity, comorbidity
pattern, and age of our sample match that of the gold-standard
MTA-study and can be regarded representative for children
referred for outpatient ADHD treatment (The MTA Cooperative
Group, 1999).
Our study set out to assess both specific and unspecific effects
of NF. An important hint for specificity is the demonstration
of successful SCP self-regulation for children in the SCP-NF
group only. The significant symptom improvement in NF may be
TABLE 7 | Comparison of parents’ and teachers’ ratings ADHD global
scale between groups.
Parents Teachers P
Mean SD Mean SD
NF pre-test 1.84 0.45 1.48 0.64 0.0002
NF post-test 2 minus pre-test −0.49 0.42 −0.21 0.54 0.01
EMG pre-test 1.78 0.47 1.38 0.71 0.0003
EMG post-test 2 minus pre-test −0.27 0.50 −0.11 0.51 0.28
regarded as a confirmation of specific effects of SCP-NF. The lack
of SCP regulation during the transfer condition in the NF group
may suggest either limited or delayed transfer and a restricted
generalization into everyday life. Here we should wait for follow-
up results as it was shown previously for patients with epilepsy
(Kotchoubey et al., 1997) and children with ADHD (Strehl et al.,
2006) that performance in transfer trials improved substantially
6-month after the end of training.
In addition, our results also point to a strong influence of
unspecific variables on treatment outcome.
We compared two treatments using identical conditions
regarding tasks, time schedule, possible amount of reinforcement,
and interaction. Children in the semi-active control group
underwent the same intense treatment in an identical setting.
In feedback treatments, contingent reinforcement of regulation
of a physiological parameter improves self-efficacy and coping
(Holroyd et al., 1984). Thus, EMG feedback may have an impact
on ADHD symptoms (by improving self-regulation skills) even
though there is no known direct relation between control of EMG
activity and the neurobiological pathology of ADHD. It has to
be noted that the type of EMG feedback used in this study is
different from the EMG feedback protocols used previously in
a couple of studies in the treatment of ADHD (for a review,
see Arnold, 2001), showing some effects compared to conditions
such as sham feedback, waiting list, keeping children busy by just
playing or listening to a story-teller. Bakhshayesh et al. (2011)
who used EMG feedback as a control condition for theta/beta-
feedback report some but smaller effects for EMG feedback
compared to frequency band NF. A comparison of tomographic
NF with EMG feedback yielded only small differences between
treatments with a tendency for EEG feedback with better
improvements (Maurizio et al., 2014). While the former study
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trained relaxation of muscles our participants had to succeed in
the simultaneous relaxation and tension of two different muscles
similar to the latter study. This differential EMG feedback is far
away from standard EMG feedback relaxation protocols aiming
to reduce hyperactivity, a core symptom of ADHD. It therefore
should be of limited specific influence on ADHD symptoms. The
finding of similarly reduced hyperactivity according to parents’
ratings in both groups fits into this consideration of unspecific
effects.
The rather small (0.40 with BOCF) or medium (0.57
completer) effect size of the between group comparisons should
be discussed in several respects. First, due to the considerable
unspecific effects in the semi-active control group the clinical
effects of NF (which also include unspecific effects) may have
been underestimated. NF-studies in ADHD with waiting list
controls tend to yield much higher effect sizes than those with
active or semi-active control conditions (see Cortese et al., 2016).
In addition, none of the NF studies published so far used the
rather conservative BOCF method. Therefore, a comparison with
those studies should consider the medium ES for the completers.
Furthermore, it must be noted that a meta-analysis of cognitive
trainings in ADHD yielded an ES of 0.37 (Cortese et al., 2015).
Similarly, for behavioral interventions the meta-analysis reported
an ES of 0.35 (Daley et al., 2014). In addition, we analyzed post hoc
within ES for our groups. Here, medium to large effect sizes of
0.78 (BOCF) and 1.09 (completer) for NF were observed, while
the effect sizes for EMG were small with 0.35 (BOCF) and 0.48
(completer).
According to teachers, who can be regarded as possibly
blinded raters, there was no group effect in favor of NF. This
is of considerable concern in the light of a recent meta-analysis
highlighting smaller effect sizes when applying probably blinded
vs. non-blinded ratings (Cortese et al., 2016). Whether NF
helps more or faster in the home setting than in school or
whether teachers are less sensitive to change than parents are still
unresolved questions.
Similar to findings from other ADHD studies (e.g., Sollie
et al., 2013), teachers compared to parents rated children as being
less affected. This may have contributed to the non-significant
findings since more pronounced baseline ADHD symptoms were
associated with a better response to NF. Within-group analysis of
our teachers’ results revealed effects of NF on the global ADHD
score, inattention, and impulsivity, while EMG feedback did not
result in such significant changes. A recent meta-analysis showed
similar results of NF based on teacher ratings on inattention
(Micoulaud-Franchi et al., 2014). Unfortunately, our study was
not powered to detect differences between treatments based on
teacher ratings, but the small effect sizes could also suggest that
the SCP-NF specific improvements may be of limited significance
in school settings. This raises the possibility that more training
sessions and transfer trials, or more sensitive blinded ratings
may be needed for SCP-NF to produce clinically significant
improvement of ADHD symptoms in school settings. However,
the observation that teachers judged the children as significantly
less affected may put these considerations into a different
perspective. If there is less clinical relevance perceived there may
be less need for and awareness of change. As discussed by Cortese
et al. (2016), teachers may be less attentive to improvements or
the instruments used should be complemented, e.g., by behavior
observation. Furthermore, teachers’ ratings being probably blind
regarding treatment allocation are not necessarily more precise.
Blinding does not validate ratings as superior per se. Recently,
Janssen et al. (2016) reported reductions in theta power that were
predictive of parents’ ratings of reduced inattention, whereas
no such association was found for (probable blinded) teachers’
ratings.
Physicians or clinical psychologists not involved in the study
rated about 27% of children in both groups as responders
based on CGI ratings. The almost identical response rate
in both groups supports the assumption of large unspecific
effects of the treatments. Unfortunately, there were about 40%
missing values. Furthermore, the validity of the clinicians’ ratings
is questionable, as some parents reported that the clinicians
asked them about their own judgment and gave their ratings
accordingly. To supplement the response ratings of clinicians, we
determined how many parents described a reduction of ADHD
total symptoms of more than 25% for their child. Here, 52% of
NF and 35% of EMG children (mITT population) were rated as
improved. This result is comparable to response rates reported
by Gevensleben et al. (2009) with 52% for NF and 29% for the
computer based attention skills training.
The a priori decision to define parents’ ratings as “primary”
was not only based on methodological requirements. Parents
observe many facets of their children’s everyday family, social
and academic life, and suffer from impairment in all these areas.
This may not only explain the more severe ratings compared
to those given by teachers but also points to the ecological
validity of their judgments. Although parents were not informed
about treatment allocation, we cannot rule out that information
given to them by their children may have affected their ratings.
Parents’ ratings were probably not blinded because children
were instructed differently according to treatment allocation.
Blinding of patients and staff may count as a gold standard
of evidence-based medicine in drug research but may interfere
in treatments where patients are expected to learn a certain
behavior or skill. This holds true for psychotherapy in general
and it is of utmost importance in feedback therapy aiming
at the acquisition of a self-regulation skill. Without knowing
which parameter has to be trained the patient may lose time,
motivation and precision (Surwit and Keefe, 1983). An important
feature even in blinded designs is the control of expectations
influencing the outcome of any treatment (Benedetti et al., 2005;
Oken, 2008). In our study, parents’ expectations had no effect on
outcome. However, their satisfaction was high and did not differ
between treatments, again pointing to the impact of unspecific
variables acting similarly in both groups. The assessment of
expectations is a first step although the psychometric quality of
the questionnaire we used is not yet assessed. We also considered
that alternative control conditions where EEG activity unrelated
to ADHD must be regulated could have reduced perceptual
awareness and allowed blinding. However, we were not aware
of any EEG activity that is completely unrelated to ADHD on
the one hand and would do no potential harm on the other
hand.
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In addition to comparing the reduction of symptoms between
groups self-regulation performance and its correlation with
clinical outcome was analyzed. This analysis yielded mixed
results: in the absence of significant correlations between self-
regulation and clinical outcome (global score) the (amount
of) specificity remains questionable. On the other hand, more
children in the EMG group than in the NF-group learned to
improve self-regulation, consistent with the results of Maurizio
et al. (2014). Subsequently, better self-regulation and learning
resulted in more positive reinforcement (i.e., more frequent
reinforcement following successful trials) for children of the
EMG group. As learning to self-regulate is acknowledged as an
important unspecific variable in biofeedback, one could have
expected more clinical improvement and superior outcomes in
the EMG group. This was not the case. Therefore, the clinical
advantage of NF is unlikely due to unspecific effects only.
Given the many ways of analyzing learning (e.g., within sessions
learning vs cross sessions as well as pre–post differences in
spontaneous as well as event-related brain activity; Gruzelier,
2014; Maurizio et al., 2014; Zuberer et al., 2015) further analyses,
including follow-up observations will give more insight in this
important matter.
For the first time, AE and SAE of SCP-NF were investigated
with the help of the WHO Adverse Reaction Terminology,
included in the Medical Dictionary for Regulatory Activities for
clinical studies (MedDRA R©, Version 16). The treatments were
feasible and AE related to the treatment were observed in only
a few children. While one child of the EMG group had to be
withdrawn from the study because his symptoms deteriorated,
the other AE in children of both groups remitted quickly.
The drop-out rate was similar to previous NF-studies
with comparable duration of treatment. Most drop-outs
were observed between pre-test and end of first treatment
phase. In accordance with evidence on ADHD treatment
utilization adherence may have been hampered by personal and
family characteristics of dropouts (higher level of oppositional
symptoms, lower paternal level of education, more single parents)
(Corkum et al., 2015). Such families may require special attention
when behavioral interventions are planned.
A difference in the change of the full scale IQ was observed
between groups. While there was a slight increase in NF,
performance of EMG participants declined. This may be due to
EMG children investing less effort in the test, and to SCP-NF
releasing attentional resources (Strehl et al., 2011).
Earlier studies have already reported improvements in
children with ADHD after SCP-NF. We have moved a step
forward in answering questions regarding specificity, efficacy and
feasibility with this study. We included the largest sample treated
with NF to date, used a semi-active control condition with an
identical setting, a conservative statistical approach (BOCF), and
SCPs as target for NF, which has been identified as a stable
marker of ADHD. Major limitations of the present study are
the lack of power regarding teacher ratings, and only few and
questionable clinicians’ ratings. Compared with other studies, a
possible shortcoming might lie in the fact that for pragmatic
reasons, we chose to conduct only 25 training sessions since Arns
et al. (2009) observed a correlation of the number of sessions with
the reduction of inattention. More sessions and more transfer
trials might have improved performance in those trials and
clinical effects might have become more robust.
Further analysis of electrophysiological and neuropsychological
data and long-term outcome will help to understand the
mechanisms underlying the reported specific and unspecific
effects. A major challenge for future studies will be to identify
predictors to decide whether an individual patient would
particularly benefit from SCP-NF.
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